Quinne Camden Sember

Quinne Sember practices at Scripps Clinic in Encinitas, California.

Quinne Sember's NPI, 1043716871, was assigned on April 2, 2018. Quinne Sember graduated from Jacobs School of Medicine and Biomedical Sciences in 2018. Quinne Sember's California license number on file is A173622.

Quinne Sember's primary practice is Scripps Clinic, at 326 Santa Fe Dr, Encinitas, CA 92024 in San Diego County. The practice phone is (858) 554-9100.

Quinne Sember's primary practice is Scripps Clinic in Encinitas, California. Quinne Sember is also affiliated with Scripps Memorial Hospital Encinitas. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Quinne Sember to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Quinne Sember practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Quinne Sember's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Quinne Sember is board certified in hematology by the American Board of Internal Medicine. Quinne Sember has a license on file in California.

CMS data shows 118 Medicare services from Quinne Sember across 3 procedure codes in 2024, for 41 Medicare patients. Medicare paid $8,302 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 41 Medicare patients who saw Quinne Sember in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have cancer, and 71% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Quinne Sember's median patient age at 62, with 93% women.

In 2024, Quinne Sember wrote 150 Medicare Part D claims for 49 patients. 77% of them were for generic drugs. CMS names the drug for 55 of them, across 2 drugs with 11 or more claims each, at $10,492 in total drug cost. In 2023, CMS named 35 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Quinne Sember for performance year 2024, reported as part of a group. Quinne Sember accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Quinne Sember as offering telehealth.

Dmand AI links 3 papers to Quinne Sember, published from 2020 to 2023. 2023 was the busiest year, with 2. Quinne Sember's most frequent co-authors are Banu K. Arun, MD, Munveer S. Bhangoo, MD and Jason Cham, MD.

CMS Open Payments shows 98 general payments to Quinne Sember from 41 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 88% of the total. Sanofi and Genzyme US Companies paid the most, $568.

Quinne Sember graduated from Jacobs School of Medicine and Biomedical Sciences in 2018.

Quinne Sember is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.